Validation of prognostic scoring and assessment of clinical benefit for patients with bone sarcomas enrolled in phase I clinical trials

BACKGROUND: We sought to validate the Royal Marsden Hospital (RMH) and MD Anderson Cancer Center (MDACC) prognostic scoring systems for the selection of bone sarcoma patients for phase I clinical trials and to identify additional risk factors related to survival. PATIENTS AND METHODS: We retrospecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Livingston, J. Andrew, Hess, Kenneth R., Naing, Aung, Hong, David S., Patel, Shreyaskumar, Benjamin, Robert S., Ludwig, Joseph A., Conley, Anthony, Herzog, Cynthia E., Anderson, Pete, Meric-Bernstam, Funda, Kurzrock, Razelle, Subbiah, Vivek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5325454/
https://www.ncbi.nlm.nih.gov/pubmed/27486883
http://dx.doi.org/10.18632/oncotarget.10910

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5325454/
https://www.ncbi.nlm.nih.gov/pubmed/27486883
http://dx.doi.org/10.18632/oncotarget.10910

Ejemplares similares